Skip to main content

Want a detailed portfolio tracker?

Kodiak Sciences (KOD) P/E (2018 - 2026)

Kodiak Sciences (KOD) P/E from Oct 4, 2018 to Jun 3, 2026. The TTM Kodiak Sciences (KOD) P/E is -8.38. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kodiak Sciences (KOD)

YearP/EChange
2026-8.38+25.74%
2025-6.66+124.26%
2024-2.97+406.34%
2023-0.59-43.81%
2022-1.04-93.63%
2021-16.38-68.23%
2020-51.56-13.24%
2019-59.44+1325.10%
2018-4.17N/A

Comparison Kodiak Sciences (KOD) P/E with competitors

Kodiak Sciences (KOD) P/E is -8.38.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.22%
ENLVEnlivex Therapeutics Ltd0.15-101.79%
FGENFibroGen Inc0.24-102.86%
TRAWTraws Pharma Inc0.47-105.64%
FBIOFortress Biotech Inc0.71-108.43%
CHRSCoherus Biosciences Inc0.98-111.67%
ORMPOramed Pharmaceuticals Inc1.47-117.58%
AGENAgenus Inc2.05-124.45%
VIVSVivoSim Labs Inc2.54-130.26%
INVAInnoviva Inc3.19-138.05%
CRMDCorMedix Inc3.65-143.51%
ABEOAbeona Therapeutics Inc4.20-150.18%
VXRTVaxart Inc4.26-150.86%
CVACCureVac N.V.4.45-153.06%
SRPTSarepta Therapeutics Inc4.62-155.19%
GLPGGalapagos NV4.86-157.99%
RIGLRigel Pharmaceuticals4.92-158.71%
ZVRAZevra Therapeutics Inc4.97-159.36%
ABUSArbutus Biopharma Corp5.69-167.95%
CGENCompugen Ltd7.38-188.12%
AUPHAurinia Pharmaceuticals Inc9.25-210.41%
ACADAcadia Pharmaceuticals Inc9.59-214.43%
OMEROmeros Corporation9.88-217.95%
PLXProtalix BioTherapeutics Inc9.91-218.26%
SPROSpero Therapeutics Inc10.73-228.11%
ADMAAdma Biologics Inc11.33-235.23%
SVASinovac Biotech Ltd11.44-236.48%
TBPHTheravance Biopharma Inc11.78-240.55%
HRMYHarmony Biosciences Holdings Inc12.18-245.37%
TGTXTG Therapeutics Inc13.18-257.29%
INCYIncyte Corp13.38-259.71%
SABSSAB Biotherapeutics Inc14.06-267.77%
XOMAXOMA Corp14.95-278.37%
REGNRegeneron Pharmaceuticals Inc14.98-278.78%
PBYIPuma Biotechnology Inc15.05-279.62%
EXELExelixis Inc15.79-288.51%
NAGENiagen Bioscience Inc16.35-295.19%
CPRXCatalyst Pharmaceuticals Inc17.34-307.00%
MDXGMimedx Group Inc17.38-307.37%
ARGXArgen X SE23.07-375.35%
HALOHalozyme Therapeutics Inc23.20-376.89%
XOMAOXOMA Corp25.34-402.48%
VRTXVertex Pharmaceuticals Inc25.66-406.19%
XOMAPXOMA Corp25.67-406.36%
CTMXCytomX Therapeutics Inc25.70-406.69%
ASNDAscendis Pharma A/S26.35-414.53%
RPRXRoyalty Pharma plc - Class A27.50-428.15%
SLNOSoleno Therapeutics Inc29.02-446.29%
LGNDLigand Pharmaceuticals Inc - Class B30.19-460.26%
BMRNBiomarin Pharmaceutical Inc37.51-547.64%
APLSApellis Pharmaceuticals Inc39.02-565.70%
KRYSKrystal Biotech Inc39.70-573.78%
GMABGenmab40.20-579.81%
ONCBeiGene Ltd67.03-899.94%
TECHBio-Techne Corp68.59-918.66%
VCELVericel Corp80.63-1062.28%
PHARPharming Group N.V.87.74-1147.15%
ALNYAlnylam Pharmaceuticals Inc124.93-1591.04%
TLXTelix Pharmaceuticals Ltd139.89-1769.54%
CORTCorcept Therapeutics Inc158.39-1990.32%